New Radiation Therapy Strategy Improves Craniospinal Irradiation Efficiency
Researchers at The Fourth Hospital of Hebei Medical University evaluated a gradient multi-isocenter volumetric modulated arc therapy strategy using an intelligent couch-shifting accelerator for craniospinal irradiation.
Key points
- Retrospective study evaluated 16 patients undergoing craniospinal irradiation.
- Increased-isocenter VMAT reduced normal tissue exposure and organ-at-risk doses.
- VMAT strategies reduced delivery time by approximately 78% compared to helical tomotherapy.
Evaluating Extended-Volume Radiotherapy Approaches
Researchers examined sixteen patients who underwent craniospinal irradiation at The Fourth Hospital of Hebei Medical University between January 2022 and March 2026 to assess the performance of a gradient multi-isocenter volumetric modulated arc therapy (VMAT) strategy. The team compared a conventional multi-isocenter configuration against an increased-isocenter setup utilizing an intelligent couch-shifting accelerator, alongside reference plans generated via helical tomotherapy.
Dosimetric Outcomes and Delivery Efficiency
The study found that raising the number of isocenters enhanced dose modulation for extended target volumes. The increased-isocenter VMAT approach reduced low-dose exposure to normal tissues and lowered mean dose values for organs at risk, including the kidneys and parotid glands, compared to the conventional method. Both VMAT configurations substantially cut delivery time by roughly seventy-eight percent relative to helical tomotherapy, while maintaining acceptable target coverage and reliable delivery accuracy.
What to know: This retrospective investigation suggests that optimized VMAT configurations may offer a practical, time-efficient alternative for complex extended-field radiotherapy. Patients should consult qualified medical professionals regarding specific treatment decisions.
Source Nature Health Sciences — nature.com/articles/s41598-026-77634-y ↗
Read next
🔬ResearchJAK Inhibitor Shows Potential in Managing Immune Dysregulation in Down Syndrome
A phase 2 clinical trial indicates that the medication tofacitinib can safely reduce chronic immune overactivity in individuals with Down syndrome, leading to improvement…
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…